We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Incidence of Hepatitis B Virus (HBV) Reactivation in HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOP (IHBVRL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01210287
Recruitment Status : Unknown
Verified January 2014 by Junning Cao, Fudan University.
Recruitment status was:  Active, not recruiting
First Posted : September 28, 2010
Last Update Posted : January 8, 2014
Information provided by (Responsible Party):
Junning Cao, Fudan University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : August 2014
  Estimated Study Completion Date : August 2014